250 related articles for article (PubMed ID: 36280517)
61. Patients with initial nodal involvement due to breast cancer who have received neoadjuvant chemotherapy: Combined sentinel node-radioguided surgery of the pathological node.
Fuertes Manuel J; Kohan S; Jordà Solé M; Mateu Hidalgo I; Miralles Curto M; Aguiló Sagristà O; Aguilar Alomá E; Peña González K; Lafuerza Torres A; Melé Olivé M; Repkova J; Montero Jaime MJ; Gumà Padró J
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2022; 41(5):284-291. PubMed ID: 35597764
[TBL] [Abstract][Full Text] [Related]
62. New horizons in imaging and surgical assessment of breast cancer lymph node metastasis.
Arjmandi F; Mootz A; Farr D; Reddy S; Dogan B
Breast Cancer Res Treat; 2021 Jun; 187(2):311-322. PubMed ID: 33982209
[TBL] [Abstract][Full Text] [Related]
63. Nanoparticle-assisted axillary staging: an alternative approach after neoadjuvant chemotherapy in patients with pretreatment node-positive breast cancers.
Yang J; He T; Wu Y; Fu Z; Lv Q; Lu S; Wang X; Li H; Wang J; Chen J
Breast Cancer Res Treat; 2022 Apr; 192(3):573-582. PubMed ID: 35129717
[TBL] [Abstract][Full Text] [Related]
64. Contrast-enhanced ultrasonography and blue dye methods in detection of sentinel lymph nodes following neoadjuvant chemotherapy in initially node positive breast cancer.
Wu X; Tang L; Huang W; Huang S; Peng W; Hu D
Arch Gynecol Obstet; 2020 Sep; 302(3):685-692. PubMed ID: 32602000
[TBL] [Abstract][Full Text] [Related]
65. Lower lymph node yield in axillary lymph node dissection specimens in breast cancer patients receiving neoadjuvant chemotherapy: Quality concern or treatment effect?
Ozao-Choy J; Moazzez A; Dauphine C
Breast J; 2021 Dec; 27(12):851-856. PubMed ID: 34877726
[TBL] [Abstract][Full Text] [Related]
66. A model to predict pathologic complete response of axillary lymph nodes to neoadjuvant chemo(immuno)therapy in patients with clinically node-positive breast cancer.
Schipper RJ; Moossdorff M; Nelemans PJ; Nieuwenhuijzen GA; de Vries B; Strobbe LJ; Roumen RM; van den Berkmortel F; Tjan-Heijnen VC; Beets-Tan RG; Lobbes MB; Smidt ML
Clin Breast Cancer; 2014 Oct; 14(5):315-22. PubMed ID: 24548732
[TBL] [Abstract][Full Text] [Related]
67. Assessment of axillary node status by ultrasound after neoadjuvant chemotherapy in patients with clinically node-positive breast cancer according to breast cancer subtype.
Maeshima Y; Sakai T; Ogiya A; Takahashi Y; Miyagi Y; Kokubu Y; Osako T; Ito Y; Takahashi S; Ohno S; Ueno T
Sci Rep; 2021 May; 11(1):10858. PubMed ID: 34035335
[TBL] [Abstract][Full Text] [Related]
68. The importance of sentinel lymph node biopsy following neoadjuvant chemotherapy in patients with breast cancer: prospective multicentre trial.
Žatecký J; Kubala O; Coufal O; Kepičová M; Gatěk J; Prokop J; Lerch M; Peteja M
Rozhl Chir; 2021; 100(6):271-276. PubMed ID: 34465116
[TBL] [Abstract][Full Text] [Related]
69. [Normalization in axillary lymph node management after neoadjuvant therapy for breast cancer].
Wu D; Liu SY; Amina M; Fan ZM
Zhonghua Wai Ke Za Zhi; 2019 Feb; 57(2):97-101. PubMed ID: 30704211
[TBL] [Abstract][Full Text] [Related]
70. Nodal Recurrence in Patients With Node-Positive Breast Cancer Treated With Sentinel Node Biopsy Alone After Neoadjuvant Chemotherapy-A Rare Event.
Barrio AV; Montagna G; Mamtani A; Sevilimedu V; Edelweiss M; Capko D; Cody HS; El-Tamer M; Gemignani ML; Heerdt A; Kirstein L; Moo TA; Pilewskie M; Plitas G; Sacchini V; Sclafani L; Tadros A; Van Zee KJ; Morrow M
JAMA Oncol; 2021 Dec; 7(12):1851-1855. PubMed ID: 34617979
[TBL] [Abstract][Full Text] [Related]
71. Feasibility of Preoperative Axillary Lymph Node Marking with a Clip in Breast Cancer Patients Before Neoadjuvant Chemotherapy: A Preliminary Study.
Kim EY; Byon WS; Lee KH; Yun JS; Park YL; Park CH; Youn IY; Choi SH; Choi YJ; Kook SH; Do SI
World J Surg; 2018 Feb; 42(2):582-589. PubMed ID: 28808843
[TBL] [Abstract][Full Text] [Related]
72. Computed tomography reconstruction for evaluating response in axillary lymph nodes of breast cancer after neoadjuvant chemotherapy.
Wang L; Li Y; Li J; Wang T; Xie Y; He Y; Fan Z; Ouyang T
Clin Transl Oncol; 2021 Feb; 23(2):240-245. PubMed ID: 32519177
[TBL] [Abstract][Full Text] [Related]
73. Response in axillary lymph nodes to neoadjuvant chemotherapy for breast cancers: correlation with breast response, pathologic features, and accuracy of radioactive seed localization.
Clark BZ; Johnson RR; Berg WA; McAuliffe P; Bhargava R
Breast Cancer Res Treat; 2023 Aug; 200(3):363-373. PubMed ID: 37286892
[TBL] [Abstract][Full Text] [Related]
74. Correlation between clinical nodal status and sentinel lymph node biopsy false negative rate after neoadjuvant chemotherapy.
Takahashi M; Jinno H; Hayashida T; Sakata M; Asakura K; Kitagawa Y
World J Surg; 2012 Dec; 36(12):2847-52. PubMed ID: 22806206
[TBL] [Abstract][Full Text] [Related]
75. Sentinel lymph node biopsy before versus after neoadjuvant chemotherapy for breast cancer.
Shimazu K; Noguchi S
Surg Today; 2011 Mar; 41(3):311-6. PubMed ID: 21365408
[TBL] [Abstract][Full Text] [Related]
76. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab.
Hsiang DJ; Yamamoto M; Mehta RS; Su MY; Baick CH; Lane KT; Butler JA
Arch Surg; 2007 Sep; 142(9):855-61; discussion 860-1. PubMed ID: 17875840
[TBL] [Abstract][Full Text] [Related]
77. A novel nomogram model of breast cancer-based imaging for predicting the status of axillary lymph nodes after neoadjuvant therapy.
Zhang P; Song X; Sun L; Li C; Liu X; Bao J; Tian Z; Wang X; Yu Z
Sci Rep; 2023 Apr; 13(1):5952. PubMed ID: 37045864
[TBL] [Abstract][Full Text] [Related]
78. Assessment of preoperative axillary nodal disease burden: breast MRI in locally advanced breast cancer before, during and after neoadjuvant endocrine therapy.
Reis J; Boavida J; Tran HT; Lyngra M; Reitsma LC; Schandiz H; Melles WA; Gjesdal KI; Geisler J; Geitung JT
BMC Cancer; 2022 Jun; 22(1):702. PubMed ID: 35752785
[TBL] [Abstract][Full Text] [Related]
79. Axillary management for patients with breast cancer after neoadjuvant chemotherapy: Results of a survey among Brazilian breast surgeons.
Frasson AL; Resende HM; Lichtenfels M; Barbosa F; de Souza ABA; Miranda I; Falcone AB
J Surg Oncol; 2020 Nov; 122(6):1247-1251. PubMed ID: 33045117
[TBL] [Abstract][Full Text] [Related]
80. Axillary lymph node response to neoadjuvant systemic therapy with dedicated axillary hybrid
de Mooij CM; Samiei S; Mitea C; Lobbes MBI; Kooreman LFS; Heuts EM; Beets-Tan RGH; van Nijnatten TJA; Smidt ML
Clin Radiol; 2022 Oct; 77(10):e732-e740. PubMed ID: 35850866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
